DNA

View All

Polymerase Chain Reaction Market Outlook and Forecast
Polymerase Chain Reaction (PCR) Market: Evaluating the Major Market Dynamics and Key Trends Driving the Growth

Polymerase Chain Reaction, commonly called PCR, is one of the most well-known methods in molecular biology utilized for amplifying target sequences from a DNA template in an exponential manner. PCR has various applications, and the scope is vast in healthcare and other related domains. It was invented in 1983 by Am...

Find More

slumber
Welcome the Slumber

Why does everyone sleep? Tired? Sleep a little. Not feeling well? Nap for a little while. Working for long? Rest a bit. For most of the things, Slumber is a solution. And now there is a scientific theory to prove that. In a recent study published in the journal Nature Communications, researchers at Bar-Ilan Uni...

Find More

Therapeutics
The Business Cocktail(Therapeutics)

Blueberry Therapeutics reels in USD 12.7 Million in series B funding for fungal infections. U.K.based, Blueberry Therapeutics successfully bagged a funding of USD 12.7 million in series B funding. The funding will help the company to advance its nanomedicine candidate, BB2603 for two fungal infections namely- Ath...

Find More

DNA typos to blame for most Cancer Mutations

Nearly two-thirds of the mutations that drive cancers are caused by errors that occur when cells copy DNA. The findings, published in Science are the latest argument in a long-running debate over how much the environment or intrinsic factors contribute to cancer. They also suggest that many cancer mutations are not ...

Find More

Liquid Biopsy: Revolutionary Technique for Cancer Diagnosis

Clinicians have been conducting biopsies for a long time, for diagnosing and managing cancer, as genetic profile of tumor is analyzed through biopsy. Tissue biopsy is a traditional biopsy technique which is a time consuming and lengthy procedure, and cannot be performed routinely. Liquid Biopsy is a next generation ...

Find More

Identity Crises Faced by a Venerable Brain-Cancer Cell Line

There has been a shocking revelation in a report published in Science Translational Medicine by Bengt Westermark, a tumour biologist at Uppsala, who reports that a cell line widely used to study brain cancer does not match the cells used to create the line nearly 50 years ago, or the tumour supposed to be its source...

Find More

The Curious Case of CRISPR Technology

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats), a gene-editing technology, has set a record by reaching clinics from the research laboratory in a very short time, as NIH’s Recombinant DNA Advisory Committee has approved the first clinical trial of the technology in the U.S. for coming June. The t...

Find More